Match tier Confirmed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-20

Nawab Ali

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI

Professor

Also affiliated: Creighton University (1992–1996); National Institutes of Health (1995); Research Triangle Park Foundation (1995); East China University of Science and Technology (2024); Pondicherry University (2025); The University of Agriculture, Peshawar (2022); Yale University (1997–1998); National Institute of Environmental Health Sciences (1995); Conway School of Landscape Design (2010); Shanghai Institute of Technology (2021); Indian Institute of Toxicology Research (1991); Michigan State University (2025)

Faculty Researcher

19 h-index 102 pubs 1,714 cited

  • Humans
  • Animals
  • Apoptosis
  • Antineoplastic Agents
  • Cell Survival
  • Inositol Phosphates
  • Photochemotherapy
  • Cell Line, Tumor
  • Nanoparticles
  • Mice
  • Rats
  • Nanomedicine
  • Membrane Proteins
  • Reactive Oxygen Species
  • MCF-7 Cells

Biography and Research Information

OverviewAI-generated summary

Nawab Ali's research focuses on the development and application of nanomedicines for cancer therapy. He has investigated enhanced photothermal heating and combination therapy using self-assembled ionic nanomaterials, as well as the cellular uptake of gold nanorods in breast cancer cell lines. His work also includes the creation of guar-based injectable hydrogels for drug delivery and bone cell growth, and the improvement of photophysical properties in ionic material-based combination chemo/phototherapy nanomedicines.

Ali has received funding from the National Science Foundation (NSF) for his I-Corps project on Nano Drug Enabled Cancer Therapy. His research has led to publications on various aspects of cancer treatment, including advanced approaches to breast cancer classification and diagnosis, tumor microenvironment-triggered theranostic nanoplatforms, and doxorubicin-based ionic nanomedicines for combined chemo-phototherapy. His scholarship metrics include an h-index of 19, 102 total publications, and 1,686 total citations.

His collaborations extend to researchers within the University of Arkansas at Little Rock, the University of Arkansas for Medical Sciences, and the University of Arkansas at Fayetteville, with multiple shared publications indicating active research partnerships.

Metrics

  • h-index: 19
  • Publications: 102
  • Citations: 1,714

Selected Publications

  • Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
    International Journal of Pharmaceutics DOI OpenAlex
  • Dichloroacetic Acid Enhances Photodynamic Therapy-Induced Regulated Cell Death in PANC-1 Pancreatic Cancer Cell Line (2025)
    International Journal of Molecular Sciences 1 citation DOI OpenAlex
  • 95 Targeting Multiple Cancer Hallmarks with Rapamycin-Loaded Gold Nanoparticles—GE11 Peptide Conjugate: A Proteomic Analysis of Pathway Suppression and Cell Death Induction (2025)
    American Journal of Clinical Pathology DOI OpenAlex
  • The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer (2025)
    Cancers 18 citations DOI OpenAlex
  • Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
    ACS Omega 1 citation DOI OpenAlex
  • Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor (2025)
    Journal of Clinical Exercise Physiology 1 citation DOI OpenAlex
  • Serum tissue plasminogen activator after cycling with blood flow restriction (2025)
    Vascular Biology 4 citations DOI OpenAlex
  • IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024)
    PubMed DOI OpenAlex
  • Encapsulation of Inositol Hexakisphosphate with Chitosan via Gelation to Facilitate Cellular Delivery and Programmed Cell Death in Human Breast Cancer Cells (2024)
    Bioengineering 4 citations DOI OpenAlex
  • Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024)
    ACS Applied Bio Materials 6 citations DOI OpenAlex
  • Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024)
    ACS Applied Nano Materials 9 citations DOI OpenAlex
  • Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy (2023)
    ACS Applied Bio Materials 7 citations DOI OpenAlex
  • Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth (2023)
    Bioengineering 17 citations DOI OpenAlex
  • Correction: Enhancing antibacterial property of aluminum foil by nanostructuring its surface through a steam treatment (2023)
    MRS Advances 1 citation DOI OpenAlex
  • Antibacterial efficacy of surface aluminum oxide nanostructures produced by hot water treatment (2023)
    Nano Express 3 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $50,000 total

NSF PI Apr 2022 - Sep 2022

I-Corps: Nano Drug Enabled Cancer Therapy

I-Corps $50,000

Collaboration Network

77 Collaborators 19 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics